Shanghai Kinetic Medical Co Ltd
SZSE:300326
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (3.3), the stock would be worth ¥5.95 (13% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.8 | ¥6.88 |
0%
|
| 3-Year Average | 3.3 | ¥5.95 |
-13%
|
| 5-Year Average | 3.7 | ¥6.68 |
-3%
|
| Industry Average | 3.8 | ¥6.78 |
-1%
|
| Country Average | 3.3 | ¥5.92 |
-14%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥3.6B
|
/ |
Oct 2025
¥1B
|
= |
|
|
¥3.6B
|
/ |
Dec 2025
¥1.4B
|
= |
|
|
¥3.6B
|
/ |
Dec 2026
¥1.6B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Kinetic Medical Co Ltd
SZSE:300326
|
4.9B CNY | 3.8 | -54.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 15.4 | 56.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 3.5 | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 5.2 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 3.4 | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 4.6 | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 6.9 | 43 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.3 | 41.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 2 | 18.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 2.6 | 23.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.5 | 20.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 3.3 |
| 70th Percentile | 6.2 |
| Max | 5 034 353.9 |
Other Multiples
Shanghai Kinetic Medical Co Ltd
Glance View
Shanghai Kinetic Medical Co., Ltd. engages in the research, development, manufacture and sale of medical devices dedicated to serve orthopedic minimally invasive surgerical needs. The company is headquartered in Shanghai, Shanghai and currently employs 1,107 full-time employees. The company went IPO on 2012-06-13. The firm is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The firm operates its business in domestic market.
